State Street Corporation 13D and 13G filings for Sage Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-18 11:37 am Sale | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | STATE STREET CORP STT | 2,926,239 4.800% | -991,983 (-25.32%) | Filing |
| 2024-01-24 10:04 am Purchase | 2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE | STATE STREET CORP STT | 3,918,222 6.530% | 3,918,222 (New Position) | Filing |